Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Sopharma AD - Filing #6022425

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2023-12-31
2022-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
727 099 BGN
681 487 BGN
Current assets
787 063 BGN
572 491 BGN
Non-current liabilities
151 346 BGN
129 998 BGN
Current liabilities
609 190 BGN
407 346 BGN
Revenue
1 875 304 BGN
1 663 016 BGN
Profit (loss)
99 874 BGN
95 977 BGN
3 897 BGN
95 977 BGN
76 333 BGN
71 121 BGN
5 212 BGN
71 121 BGN
Other comprehensive income
3 915 BGN
3 999 BGN
84,000 BGN
1 388 BGN
30,000 BGN
3 591 BGN
1 766 BGN
5 868 BGN
1 355 BGN
143,000 BGN
892,000 BGN
1 047 BGN
6 011 BGN
5 427 BGN
Comprehensive income
103 789 BGN
30,000 BGN
94 589 BGN
3 591 BGN
99 976 BGN
3 813 BGN
1 766 BGN
70 465 BGN
72 476 BGN
5 355 BGN
892,000 BGN
1 047 BGN
65 110 BGN
5 427 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.